Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Monitoring the interaction between β2-microglobulin and the molecular chaperone αB-crystallin by NMR and mass spectrometry

Thumbnail Image

Date

2013

Authors

Esposito, Gennaro
Garvey, Megan
Alverdi, Vera
Pettirossi, Fabio
Corazza, Alessandra
Fogolari, Federico
Polano, Maurizio
Mangione, P. Patrizia
Giorgetti, Sofia
Stoppini, Monica

Journal Title

Journal ISSN

Volume Title

Publisher

American Society for Biochemistry and Molecular Biology Inc

Abstract

The interaction at neutral pH between wild-type and a variant form (R3A) of the amyloid fibril-forming protein β2-microglobulin (β2m) and the molecular chaperone αB-crystallin was investigated by thioflavin T fluorescence, NMR spectroscopy, and mass sp

Description

Keywords

Keywords: Amyloid fibril formation; Coefficient measurement; Fibril formation; Molecular chaperones; NMR diffusion; NMR spectrum; Non-fibrillar; Thioflavin T; Diffusion; Nuclear magnetic resonance spectroscopy; Oligomerization; Oligomers; Mass spectrometry; alpha c

Citation

URI

http://hdl.handle.net/1885/62197

Collections

ANU Research Publications

Source

Journal of Biological Chemistry

Type

Journal article

Book Title

Entity type

Access Statement

Open Access

License Rights

DOI

10.1074/jbc.M112.448639

Restricted until

Downloads

File
Description
01_Esposito_Monitoring_the_interaction_2013.pdf (3.37 MB)

DSpace software copyright © 2002-2026 LYRASIS